In the competitive bio-pharma landscape, achieving excellence requires a strategic blend of quality, efficiency, and cost-effectiveness. Pro Pharma Research Organization stands out as your ideal nearshore partner, offering unp
The relationship between medical information, real-world evidence (RWE), and marketing in the pharmaceutical industry is interconnected and plays a crucial role in the development, approval, and commercialization of new treatments.
Post-marketing surveillance (PMS) is crucial in veterinary products to ensure continued safety and efficacy after a product has been approved and is on the market.
Project-based pods in medical affairs and real-world evidence (RWE) for pharma are collaborative, cross-functional teams designed to tackle specific projects or challenges.
In Latin America, particularly in Mexico and Brazil, pharmacovigilance has gained relevance in recent decades due to increasing access to medicines and the need to ensure their safety and efficacy.
Veterinary pharmacovigilance is an essential component in the field of veterinary medicine, responsible for the detection, assessment, understanding, and prevention of adverse effects of medications in animals.
A Qualified Person for Pharmacovigilance (QPPV) is a regulatory requirement in the European Union (EU) for pharmaceutical companies involved in the marketing and distribution of medicinal products.
The process of bringing a drug from the laboratory to the market is complex and highly regulated. Preparing regulatory packages, interacting with regulatory agencies, and post-launch compliance are critical stages to ensure the safety and efficacy of the product.
The execution of clinical trials is a complex and rigorous process that requires meticulous planning and strict adherence to regulations to ensure data integrity and patient safety.
